当前位置: 主页 > 杭州信息之窗 > 新闻资讯 > 正文

南亚的孟加拉却领先其邻国率先仿制并且上市了

来源: 未知 2016-07-22 杭州信息之窗

阿斯利康的新药AZD9291塔格瑞斯(Osimertinib)是一种口服的小分子第三代表皮生长因子酪氨酸激酶抑制剂(EGFR-TKI)。

对于易瑞沙、特罗凯、凯美纳已经耐药的晚期非小细胞肺癌患者，AZD9291塔格瑞斯(Osimertinib)无疑是最好的选择。

可是AZD929原研产品十多万元一疗程的价格成了发展中国家患者追求治疗的最大障碍。所以很多患者把希望寄托于仿制药大国印度的强行仿制。

http://www.xingfu.jknews.cn/article/201607/22120630.html

http://www.dasu.jueche.cn/2016/0722120631.htm

http://www.jlit.kjnews.com.cn/html/201607120632.htm

http://www.ynit.kjnews.com.cn/news/201607/22120633.html

http://www.hubei.mpnews.cn/xinwen/201622120634.htm

http://www.cqpp.mpnews.cn/news/201622120635.htm

http://www.zjmpw.mpnews.cn/html/201607120636.shtml

http://www.shijie.mpnews.cn/html/201607120637.htm

http://www.anhui.mpnews.cn/2016/0722120638.shtml

http://www.shandong.mpnews.cn/news/201607/22120639.shtml

http://www.tianjing.mpnews.cn/article/201622120640.shtml

http://www.beijing.mpnews.cn/xinwen/201622120641.shtml

http://www.sxpp.mpnews.cn/article/201622120642.html

http://www.sanxi.mpnews.cn/news/201622120643.shtml

http://www.jilin.mpnews.cn/html/201607120644.shtml

http://www.hljpp.mpnews.cn/2016/0722120645.shtml

http://www.liaoning.mpnews.cn/news/201607/22120646.shtml

http://www.ningxia.mpnews.cn/xinwen/201607/22120647.shtml

http://www.xinwen.mpnews.cn/201607/12064822.shtml

http://www.jh.zjvnet.com/html/201607/22120649.shtml

http://www.hz.zjvnet.com/html/201607/22120650.html

http://www.hebei.mpnews.cn/201607/22120651.html

http://www.sxkj.kjnews.com.cn/news/201607/22120652.htm

http://www.guizhouw.kjnews.com.cn/2016/0722120653.html

http://www.cqkjnews.kjnews.com.cn/article/201607/22120654.htm

http://www.jiangsu.mpnews.cn/201607/22120655.shtml

http://www.jiangxiw.kjnews.com.cn/article/201622120656.htm

http://www.anhuiw.kjnews.com.cn/xinwen/201622120657.html

http://www.guangdongs.kjnews.com.cn/news/201622120658.html

http://www.tianjings.kjnews.com.cn/html/201607120659.html

http://www.jsitol.kjnews.com.cn/201607/12066022.html

http://www.hljkj.kjnews.com.cn/xinwen/201622120661.htm

http://www.ynpp.mpnews.cn/html/201607/22120662.htm

http://www.liaoningw.kjnews.com.cn/xinwen/201607/22120663.html

http://www.zuixin.kjnews.com.cn/article/201607/22120664.htm

http://www.dianxun.maigei.cn/news/201607/22120665.htm

http://www.shangye.maigei.cn/news/201622120666.htm

http://www.qinghai.mpnews.cn/xinwen/201607/22120667.htm

http://www.gspp.mpnews.cn/xinwen/201607/22120668.shtml

http://www.hunan.mpnews.cn/201607/22120669.htm

http://www.hefei.ahdaily.cn/article/201622118346.html

http://www.dongbei.bfrxw.com/article/201607/22118347.html

http://www.qiyew.bfrxw.com/news/201607/22118348.html

http://www.hsol.ahdushi.cn/xinwen/201622118349.html

http://www.wuxi.jsdaily.cn/html/201607118350.html

http://www.longnan.gsdaily.cn/201607/22118351.html

http://www.changchun.jldaily.cn/xinwen/201607/22118352.html

http://www.chengde.hbdaily.cn/html/201607/22118353.html

http://www.sichuan.gddaily.cn/2016/0722118354.html

http://www.tj.cknews.cn/xinwen/201622118355.html

http://www.gufu.tjvnet.cn/xinwen/201622118356.html

http://www.daqing.hjnews.cn/html/201607118357.html

http://www.lanzhou.sfnews.cn/xinwen/201622118358.html

http://www.js.mknews.cn/201607/22118359.html

http://www.nl.jldaily.cn/news/201607/22118360.html

http://www.fsbc.gddaily.cn/news/201607/22118361.html

http://www.jyg.gsdaily.cn/article/201607/22118362.html

http://www.dalian.lnxxg.cn/20160722/118363.html

http://www.guizhou.gzdushi.cn/article/201607/22118364.html

http://www.gyol.gzdushi.cn/news/201607/22118365.html

http://www.zhuhai.gdrxw.cn/2016/0722118366.html

http://www.xx.fjvnet.com/201607/22118367.html

http://www.hhzx.kfnews.com.cn/article/201622118368.html

http://www.sx.cknews.cn/xinwen/201607/22118369.html

http://www.sx.sfnews.cn/news/201622118370.html

http://www.ah.mknews.cn/html/201607/22118371.html

http://www.qixun.dailyd.cn/201607/22118372.html

http://www.gz.gddaily.com/html/201607/22118373.html

http://www.gz.nfdushi.com/news/201622109285.html

http://www.ytbc.sddaily.cn/article/20160722/109286.html

http://www.cqzx.wrnews.cn/xinwen/20160722/109287.html

http://www.hainan.pwnews.cn/2016/0722109288.html

http://www.jhbc.zjdushi.cn/xinwen/201607/10928922.html

http://www.fs.gdrxw.cn/201607/22109290.html

http://www.gf.nfdushi.com/html/201607109291.html

http://www.huaihe.ahdaily.cn/xinwen/201607/22109292.html

http://www.thrx.jldaily.cn/news/201607/22109293.html

http://www.nanjing.jsdaily.cn/html/201607/22109294.html

http://www.sjznews.hbdaily.cn/news/201607/22109295.html

http://www.wanwang.ahdaily.cn/news/201607/22109296.html

http://www.jinggu.tjvnet.cn/news/201607/22109297.html

http://www.yu.kfnews.com.cn/xinwen/201607/22109298.html

http://www.yc.nxdaily.cn/news/201607/22109299.html

http://www.nc.jxdaily.cn/2016/0722109300.html

http://www.jinan.sddaily.cn/201607/22109301.html

http://www.dh.qhdaily.cn/html/201607/22109302.html

http://www.szol.gddaily.com/article/201607/22109303.html

http://www.baoding.hbdaily.cn/xinwen/201607/22109304.html

http://www.jianghuai.ahdushi.cn/article/201607/22109305.html

http://www.guangzhou.gdrxw.cn/news/201607/22109306.html

http://www.shenyang.lnxxg.cn/201607/22109307.html

http://www.ycrb.gzdushi.cn/2016/0722109308.html

http://www.taikang.tknews.cn/xinwen/201607/22109309.html

http://www.gc.kcnews.cn/article/201607/22109310.html

http://www.aiguo.qnnews.com.cn/html/201607/22109311.html

http://www.sznet.jsdaily.cn/201607/22109312.html

http://www.anshan.lnxxg.cn/2016/0722109313.html

http://www.fj.pwnews.cn/2016/0722109314.html

http://www.bj.cknews.cn/201607/22109315.html

然而这次同在南亚的孟加拉却领先其邻国率先仿制并且上市了AZD9291。

小白海外医疗咨询公司在南亚，东南亚拥有丰富的医疗资源网络，可以协助您以最低的价格赴孟加拉购买正品药品。我们提供签证、酒店、医院、一站式服务，让您以最快的速度，最低的价格，获得最好的治疗。

[责任编辑：]

南亚的孟加拉却领先其邻国率先仿制并且上市了

网友评论:

已有1条评论

财讯看台

关山月美术馆展出百米国画长卷

　　一百幅济公画像,每幅高2.4米,连接起来共长100米，生动地刻画了民间传说人物济公荒诞不...

关山月美术馆举办著名画家马哲

　　马哲人物画展在关山月美术馆举办开幕式现场嘉宾合影 7月11日上午，在深圳关山月美术...

这些新闻24小时最热

热点组图

南亚的孟加拉却领先其邻国率先仿制并且上市了

都市贝贝玩具童车开创

都市贝贝举办2016“手

深圳太生源健康产业王

都市贝贝儿童车为“

南亚的孟加拉却领先其邻国率先仿制并且上市了

都市贝贝玩具童车开创

都市贝贝举办2016“手

深圳太生源健康产业王

都市贝贝儿童车 为“

都市贝贝儿童车为“